IP Library Granted Patent US 11,116,210
Granted Patent B2
US 11,116,210 · App. 16/186,540 · Granted Sep 14, 2021

Annatto extracts for insect repellency, larvicidal activity and methods of use

Inventors: Barrie Tan (Amherst, MA); Jia Zhang (Amherst, MA)
Assignee: AMERICAN RIVER NUTRITION, LLC
A01N27/00A01N31/02A01N49/00A01N65/00A01N65/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,210
App. No.
16/186,540
Granted
Sep 14, 2021
Kind
B2
Abstract

Health concerns of the vector-borne diseases, such as, yellow fever, malaria, dengue fever and general discomfort due to insect bites, has encouraged the development of insecticides to kill insects and insect repellents to keep insects away from treated human skin. Annatto extracts as a natural insect repellent and insecticide have many advantages over synthetic such as lower harmful side effects, low resistance, and more environmentally friendly. Annatto extracts containing ishwarane (C15) and geranyl-α-terpinene (C20) have strong mosquito repellency. Annatto extracts containing geranyl-α-terpinene (C20) and geranylgeraniol (C20) have strong larvicidal activity. Annatto extracts with approximately equal C15 and C20 composition have insect repellency, and annatto extracts with mainly C20 composition have larvicidal activity. Annatto extracts have synergistic effects with other natural extracts.

Claims (19)

1. A composition comprising ishwarane and geranyl-α-terpinene, wherein the ratio of ishwarane to geranyl-α-terpinene is 60:40 to 40:60 by volume and wherein the concentration of geranyl-α-terpinene is from 10% to 25% of the total volume of the composition.

2. A composition comprising geranylgeraniol, geranyl-α-terpinene, ishwarane, 15-hydroxy-α-muurolene, and cembrene, wherein the concentration of geranyl-α-terpinene is from 10% to 25% of the total volume of the composition, the concentration of ishwarane is from 5% to 25% of the total volume of the composition, the concentration of 15-hydroxy-α-muurolene is from 1% to 10% of the total volume of the composition, the concentration of cembrene is from 1% to 15% of the total volume of the composition, and the concentration of geranylgeraniol is from 5% to 35% of the total volume of the composition.

3. The composition of claim 1 further comprising 15-hydroxy-α-muurolene, cembrene, and geranylgeraniol.

4. The composition of claim 3 , wherein the concentration of ishwarane is from 10% to 20% of the total volume of the composition, the concentration of 15-hydroxy-α-muurolene is from 3% to 17% of the total volume of the composition, the concentration of geranyl-α-terpinene is from 15% to 20% of the total volume of the composition, the concentration of cembrene is from 5% to 10% of the total volume of the composition, and the concentration of geranylgeraniol is from 10% to 30% of the total volume of the composition.

5. A composition comprising two C15 compounds and three C20 compounds, wherein the total concentration of the C15 compounds is from 1% to 40% of the total volume of the composition and the total concentration of the C20 compounds is from 10% to 70% of the total volume of the composition, wherein the two C15 compounds are ishwarane and 15-hydroxy-α-muurolene and the three C20 compounds are geranyl-α-terpinene, cembrene, and geranylgeraniol.

6. The composition of claim 5 , wherein the concentration of C15 compounds is from 5% to 30% of the total volume of the composition and the concentration of C20 compounds is from 15% to 60% of the total volume of the composition.

7. The composition of claim 6 , wherein the concentration of C15 compounds is from 10% to 20% of the total volume of the composition and the concentration of C20 compounds is from 20% to 50% of the total volume of the composition.

8. The composition of claim 3 , wherein the concentration of ishwarane is 20% of the total volume of the composition, the concentration of 15-hydroxy-α-muurolene is 5% of the total volume of the composition, the concentration of geranyl-α-terpinene is 22% of the total volume of the composition, the concentration of cembrene is 10% of the total volume of the composition, and the concentration of geranylgeraniol is 6% of the total volume of the composition.

9. The composition of claim 3 , further comprising at least one of peppermint oil, lemongrass oil, spearmint oil, cinnamon oil, and oil of lemon eucalyptus.

10. The composition of claim 2 , wherein the concentration of ishwarane is 9% of the total volume of the composition, the concentration of 15-hydroxy-q-muurolene is 5% of the total volume of the composition, the concentration of geranyl-q-terpinene is 16% of the total volume of the composition, the concentration of cembrene is 3% of the total volume of the composition, and the concentration of geranylgeraniol is 23% of the total volume of the composition.

11. A method of repelling an arthropod away from human skin comprising applying topically the composition of claim 1 on the human skin.

12. The method of claim 11 , wherein the arthropod is selected from the group consisting of insect and arachnid.

13. A method of killing an arthropod comprising contacting the composition of claim 2 to the arthropod.

14. The method of claim 13 , wherein the arthropod is selected from the group consisting of insect and arachnid.

15. A method of repelling or killing an arthropod away from, or on, human skin comprising topically applying the composition of claim 3 on the human skin.

16. The method of claim 15 , wherein the arthropod is selected from the group consisting of insect and arachnid.

17. The method of claim 11 , wherein the composition is as effective as 20% of N,N-diethyl-3-methylbenzamide (DEET) for a 2 hour repellency duration.

18. The method of claim 15 , wherein the composition has a LD 50 from about 34 μl/L to about 282 μl/L in water at about 24 hours after application of the composition.

19. The method of claim 15 , wherein the composition has a LD 95 from about 1.3 ml/L to about 4.5 ml/L in water at about 24 hour after application of the composition.

Assignments (2)
SECURITY INTEREST Recorded May 1, 2025
From: AMERICAN RIVER NUTRITION, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 070998/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2020
From: TAN, BARRIE; ZHANG, JIA
To: AMERICAN RIVER NUTRITION, LLC
Reel/Frame 052297/0276 →
Continuity (2)
Provisional Application 62584641 · Nov 10, 2017
Related Publication 20190141995A1 · May 16, 2019